Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.
MUCO-DAP
Extra Pulmonary Determinants of Physical Activity in Adults With Cystic Fibrosis.
1 other identifier
observational
80
1 country
1
Brief Summary
Physical activity seems to be a prognostic factor for quality of life and survival in patients with cystic fibrosis (CF). Whereas their exercise capacity has been assessed through medical examination, their daily physical activity has been little studied. Activity monitors have measured physical activity only in a few studies which considered mainly respiratory status and more recently bone mineral density and body composition. Determinants of physical activity in patients with CF remain largely unknown. The objective of this study is to measure daily physical activity with activity monitors in adult patients with CF and to investigate the determinants of physical activity, with a focus on extra-respiratory factors (nutritional status, diabetes, bone mineralization, anxiety and/or depression, cardiac impairment). Seventy adult patients with CF, regularly cared at the Cochin adult CF centre, will be recruited in a stable period during their annual review. During this assessment, laboratory tests will be carried out (especially parameters for nutritional status), as well as measurement of body composition and bone mineral density, respiratory function tests and a 6 minute walk test, and echocardiography. Patients will wear for 7 consecutive days a multi-sensor armband SenseWear on the arm, to assess the intensity of physical activity in metabolic equivalents (METS) and steps per day. Finally, patients will complete three self-administered questionnaires: Quality of Life (CFQ14 +), hospital anxiety depression scale and physical activity. After a descriptive analysis of the study cohort, we will study qualitative and quantitative criteria related to physical activity (assessed quantitatively by the number of steps/day or metabolic equivalents). Linear regression models will then be developed to assess the independent factors associated with physical activity, adjusting for different variables of interest related to patients demographic, behavioral, clinical (respiratory and non-respiratory ) and biological parameters. Conversely, the "predictive" independent aspect of physical activity will be studied according to respiratory function, nutritional status and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2013
CompletedFirst Submitted
Initial submission to the registry
May 3, 2013
CompletedFirst Posted
Study publicly available on registry
May 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2016
CompletedNovember 20, 2025
October 1, 2025
1.4 years
May 3, 2013
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Steps per day
The armband indicates the mean number of steps per day over a 7-day period
Day 7
Physical activity level
The investigators determine the physical activity level by dividing total daily energy expenditure by whole-night sleeping energy expenditure
Day 7
Study Arms (1)
physical activity CF cohort
adult patients with CF at time of their yearly assessment at Cochin adult CF centre
Eligibility Criteria
Adult patients with CF cared at Cochin adult CF centre, Paris
You may qualify if:
- Patients with CF (positive sweat test or 2 disease causing CFTR mutations)
- Aged 18 or older
- Regularly cared at Cochin adult CF centre
- In clinical stable status
You may not qualify if:
- Pulmonary exacerbation in the 4 previous weeks
- IV antibiotic course for pulmonary exacerbation in the 2 previous weeks
- Pregnancy in female patients
- Patient with history of lung transplantation
- Patient on a waiting list for lung transplantation
- Treatment of diabetes initiated for less than 3 months
- Enteral nutrition initiated for less than 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cochin Hospital
Paris, 75014, France
Related Publications (3)
Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, Gosselink R, Decramer M, Dupont L. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009 Jan;33(1):99-106. doi: 10.1183/09031936.00091607. Epub 2008 Aug 20.
PMID: 18715878BACKGROUNDTejero Garcia S, Giraldez Sanchez MA, Cejudo P, Quintana Gallego E, Dapena J, Garcia Jimenez R, Cano Luis P, Gomez de Terreros I. Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest. 2011 Aug;140(2):475-481. doi: 10.1378/chest.10-1508. Epub 2011 Feb 3.
PMID: 21292759BACKGROUNDWatz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008 Apr 1;177(7):743-51. doi: 10.1164/rccm.200707-1011OC. Epub 2007 Nov 29.
PMID: 18048807BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominique Hubert, MD
Université Paris-Centre, AP-HP
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2013
First Posted
May 7, 2013
Study Start
February 21, 2013
Primary Completion
July 30, 2014
Study Completion
March 30, 2016
Last Updated
November 20, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share